FibroGen FGEN 深 滬
等待開盤 08-05 09:30:00 美东时间
6.93
+0.040
+0.58%
華盛通- 最 高7.10
- 今 開6.81
- 成交量 3.23万股
- 最 低 6.72
- 昨 收 6.89
- 總市值 2800.97万
- 52周最高 21.9375
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.50
- 委 比 50.00%
- 總股本 404.18万
- 歷史最高 1713.75
- 量 比 1.49
- 振 幅 5.52%
- 歷史最低 4.50
- 每 手 1
- 風險率 0.61%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多FibroGen to Report Second Quarter 2025 Financial Results
FibroGen, Inc. will announce its second quarter 2025 financial results on Monday, August 11, after market close. A conference call and webcast will be held at 5:00 PM Eastern Time to discuss the results, with registration links provided. FibroGen, a biopharmaceutical company specializing in therapies for cancer and anemia, currently markets Roxadustat for treating anemia in chronic kidney disease patients. They are developing Roxadustat for anemi...
08-04 20:02
FibroGen Amends Financing Agreement with Morgan Stanley
FibroGen ( ($FGEN) ) has issued an announcement. On July 14, 2025, FibroGen ame...
07-15 05:29
FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank
FibroBiologics announced advancements in its cartilage repair program, confirming that its CYWC628 spheroids can be directly differentiated into chondrocytes. This breakthrough enables the company to use its existing master cell bank to develop CybroCell™, an investigational cell therapy for degenerative disc disease (DDD). The milestone supports regulatory filings for a planned Phase I clinical trial and highlights the scalability of its fibrobl...
07-09 12:30
FibroGen Enters New Agreement with HiFiBiO
The latest update is out from FibroGen ( ($FGEN) ). On June 12, 2025, FibroGen ...
06-14 04:42
Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Shares of RH (NYSE:RH) rose sharply in today's pre-market trading as the compan...
06-13 17:08
Adobe, RH And 3 Stocks To Watch Heading Into Friday
With U.S. stock futures trading lower this morning on Friday, some of the stock...
06-13 11:39
FibroGen shares are trading lower after the company announced a 1-for-25 reverse stock split.
FibroGen shares are trading lower after the company announced a 1-for-25 revers...
06-13 04:03
FibroGen Announces 1-for-25 Reverse Stock Split
FibroGen, Inc. announced a 1-for-25 reverse stock split of its common stock, effective June 16, 2025. The split aims to increase the per-share price to meet Nasdaq's minimum bid requirement. The number of outstanding shares will reduce from approximately 101.1 million to 4.0 million. Shareholders will receive cash for any fractional shares. The stock will resume trading on June 17 under the same symbol "FGEN" with a new CUSIP number. FibroGen foc...
06-12 20:02
FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors
FibroGen, Inc. announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025. Dr. Kauffman, a biotech industry veteran with over 30 years of experience, especially in oncology, brings extensive leadership and drug development expertise. His insights will support FibroGen's pipeline progress and clinical milestones. Dr. Kauffman currently serves as CEO of Nereid Therapeutics and holds various board roles in oth...
06-09 20:02
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Theriva Biologics (AMEX:TOVX) stock moved upwards by 47.4% to $0.72 du...
06-03 05:05
